Zurich Cantonal Bank
KNSA icon

Zurich Cantonal Bank’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Zurich Cantonal Bank’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$728K Sell
15,111
-1,822
-11% -$80.7K ﹤0.01% 1612
2025
Q4 		$698K Buy
16,933
+1,446
+9% +$58K ﹤0.01% 1565
2025
Q3 		$601K Hold
15,487
– – ﹤0.01% 1636
2025
Q2 		$429K Hold
15,487
– – ﹤0.01% 1758
2025
Q1 		$344K Hold
15,487
– – ﹤0.01% 1819
2024
Q4 		$306K Buy
15,487
+7,934
+105% +$181K ﹤0.01% 1931
2024
Q3 		$189K Buy
+7,553
New +$184K ﹤0.01% 2139
2024
Q2 		– Sell
-7,555
Closed -$149K – 2683
2024
Q1 		$149K Buy
7,555
+664
+10% +$13K ﹤0.01% 2212
2023
Q4 		$121K Sell
6,891
-120
-2% -$1.97K ﹤0.01% 2353
2023
Q3 		$122K Sell
7,011
-340
-5% -$5.73K ﹤0.01% 2267
2023
Q2 		$104K Sell
7,351
-322
-4% -$4.31K ﹤0.01% 2338
2023
Q1 		$82.6K Buy
7,673
+1,694
+28% +$22.3K ﹤0.01% 2391
2022
Q4 		$89.6K Sell
5,979
-2,570
-30% -$37.4K ﹤0.01% 2338
2022
Q3 		$110K Hold
8,549
– – ﹤0.01% 2142
2022
Q2 		$83K Buy
8,549
+1,385
+19% +$12.9K ﹤0.01% 2364
2022
Q1 		$71K Hold
7,164
– – ﹤0.01% 2425
2021
Q4 		$84K Buy
7,164
+5,327
+290% +$65.5K ﹤0.01% 2585
2021
Q3 		$21K Hold
1,837
– – ﹤0.01% 2777
2021
Q2 		$26K Hold
1,837
– – ﹤0.01% 2558
2021
Q1 		$34K Hold
1,837
– – ﹤0.01% 2482
2020
Q4 		$32K Hold
1,837
– – ﹤0.01% 2531
2020
Q3 		$28K Buy
+1,837
New +$34.5K ﹤0.01% 2418

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Zurich Cantonal Bank's KNSA Position: Q1 2026 in Review

Zurich Cantonal Bank reduced its Kiniksa Pharmaceuticals (KNSA) stake by 11% in Q1 2026, selling an estimated $80.7K and leaving 15,111 shares worth $728K. The position accounts for ﹤0.01% of the portfolio, ranked #1612.

Zurich Cantonal Bank first reported a position in KNSA in Q3 2020 and has held it in 22 quarters since. 228 funds tracked by Wall St. Rank hold KNSA as of Q1 2026.

  • Zurich Cantonal Bank held 15,111 shares of Kiniksa Pharmaceuticals worth $728K as of Q1 2026.
  • Zurich Cantonal Bank sold 1,822 Kiniksa Pharmaceuticals shares in Q1 2026, an estimated $80.7K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #1612 holding.
  • Zurich Cantonal Bank first reported a position in Kiniksa Pharmaceuticals in Q3 2020 and has held it in 22 quarters since.
  • 228 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.